HomeAXSM • BMV
add
Axsome Therapeutics Inc
Previous close
$1,519.00
Year range
$1,519.00 - $1,519.00
Market cap
8.38B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 196.00M | 65.03% |
Operating expense | 219.70M | 29.32% |
Net income | -28.56M | 61.88% |
Net profit margin | -14.57 | 76.90% |
Earnings per share | -0.56 | 63.64% |
EBITDA | -32.12M | 45.44% |
Effective tax rate | -1.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 322.93M | 2.40% |
Total assets | 689.80M | 21.34% |
Total liabilities | 601.51M | 17.60% |
Total equity | 88.30M | — |
Shares outstanding | 51.15M | — |
Price to book | 872.99 | — |
Return on assets | -13.25% | — |
Return on capital | -30.08% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -28.56M | 61.88% |
Cash from operations | -18.65M | 28.81% |
Cash from investing | -71.00K | -136.67% |
Cash from financing | 16.38M | 15.03% |
Net change in cash | -2.34M | 80.49% |
Free cash flow | -6.61M | -327.09% |
About
Founded
2012
Website
Employees
925
